PAPER Seo JS, Baek IS, Leem YH, Kim TK, Cho Y, Lee SM, Park YH, Han PL
SEARCH RESULTS
329930 RESULTS
PAPER Robinson KM
Policy issues in mental health among the elderly.
Nurs Clin North Am. 2010 Dec;45(4):627-34, vii. PubMed: 20971341PAPER Cito A, Porcelli B, Coppola MG, Mangiavacchi P, Cortelazzo A, Terzuoli L
Analysis of serum levels of homocysteine and oxidative stress markers in patients with Alzheimer disease.
Biomed Pharmacother. 2010 Oct 22; PubMed: 20971604PAPER Wirths O, Erck C, Martens H, Harmeier A, Geumann C, Jawhar S, Kumar S, Multhaup G, Walter J, Ingelsson M, Degerman-Gunnarsson M, Kalimo H, Huitinga I, Lannfelt L, Bayer TA
Identification of low molecular weight pyroglutamate A{beta} oligomers in Alzheimer disease: a novel tool for therapy and diagnosis.
J Biol Chem. 2010 Dec 31;285(53):41517-24. PubMed: 20971852Sara Park
Cambridge, United States
Markus Britschgi on A gene expression pattern in blood for the early detection of Alzheimer's disease.
COMMENT Several groups have already reported that various subgroups of blood cells seem to differ between AD patients and cognitively normal subjects either by number, function, or overall gene expression. So, to me, it is not a big surprise that the team working
Brian Freibaum on Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue.
COMMENT This paper by Liqun Liu-Yesucevitz and colleagues is an important contribution in understanding the role that TDP-43 plays in human diseases such as ALS and FTLD. This is a solid publication that confirms previous studies that demonstrate TDP-43 is presen
PAPER Elvira G, Wasiak S, Blandford V, Tong XK, Serrano A, Fan X, del Rayo Sánchez-Carbente M, Servant F, Bell AW, Boismenu D, Lacaille JC, McPherson PS, DesGroseillers L, Sossin WS
Characterization of an RNA granule from developing brain.
Mol Cell Proteomics. 2006 Apr;5(4):635-51. PubMed: 16352523Brian Freibaum
United States
Koen Bossers
Netherlands Institute for NeuroscienceAmsterdam, Netherlands
Bill Finley
Mission HospitalsAsheville, United States
David Harrison
Takeda Cambridge LtdCambridge
Odete Cruz e Silva
Universidade de AveiroAveiro, Portugal
PrP Sc and recPrP (6D11)
ANTIBODY monoclonal 6D11 laboratory 6D11<br />(R.J. Kascsak, Department of Neurology, New York University School of Medicine, New York, NY<br />Paper, <a href="http://www.jleukbio.org/cgi/content/full/81/6/1374" target="_new">
Peter Davies on Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model.
COMMENT The results described are surprising, and do not readily fit with the work from Mucke's group on fyn. It is also amazing how the loss of STEP corrects the behavioral impairment, without modifying the underlying pathology at all—at least at this early
Current Filters
No filters selected